Bio-Rad's study demonstrating utility of its SpyLock technology for fast generation and screening of bispecific antibodies
Study Describes Method to Successfully Modify the Functional Activity of SpyCatcher Protein for the Rapid Generation and High-Throughput Screening of Bispecific Antibodies
The end of high drug prices? Exploring the potential and limits of PDABs
Certain states in the US have enacted or are actively considering legislation to create PDABs, Prescription Drug Affordability Boards.
Pupils from The Galfrid School learn about DNA
Children at the primary school took part in an interactive morning learning DNA and genetics.
Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee
Enables unique vector and process optimizations for different molecules to increase the likelihood of high titer clonal cell lines. Asimov now guarantees titers of 5 g/L for IgG monoclonal antibodies, as part of its Cell Line Development (CLD) ServiceSapio Sciences and Zifo announce strategic partnership
Industry leaders to provide world-class lab informatics platform, services and support to life science customersBaltimore, MD, 30 July 2024 – Sapio Sciences, the science-aware™ lab informatics pla
Introducing our state-of-the-art human factors study facility
Springboard Pro Ltd writes: we are pleased to announce an enhancement to our human factors capabilities with the introduction of our new dedicated human factors facility.
EnterpriseWOMEN - going beyond conventions in business model innovation
From researcher to founder: increasing the number of women founders through hands-on, practical learning experiences.
Addressing asthma misdiagnosis in primary care
Co-authored by Dr. Andrew Potter, Whaddon Medical Centre
Metaverse or the office… What would you really prefer?
The metaverse, a digital universe combining virtual reality (VR) and augmented reality (AR) was supposed to transform the future of office work. However, that doesn’t seem to have happened (yet) Steve Jobs said “You’ve got to start with the customer experience and work backward to the technology. You can’t start with the technology then try to figure out where to sell it.”
CrestOptics’ CICERO spinning disk confocal system receives Top 10 Best Microscopy Innovation Award from Microscopy Today
Awards announced at Microscopy & Microanalysis Meeting, Cleveland, Ohio, 28th July – 1st August, 2024
The role of technology in respiratory care
In this episode Dr. Bipin Patel is joined by Dr. Andrew Potter, the GP lead at Whaddon Medical Centre, Milton Keynes Community Respiratory Service and the Milton Keynes Home Oxygen Assessment Service. Dr.
Empowering children and young people to become DNA heroes
D-CYPHR attended Leicester Grammar School STEM fair to highlight how every family can help childhood health research. Children and young people at the school have been involved in D-CYPHR for a while and it was a great chance to bring the project to life.
Clinic Pledge launches to help fertility patients juggle work and treatment
Patient charity Fertility Network has developed the ‘Fertility in the Workplace’ initiative to help employees and employers communicate better for mutual benefit. It is now looking at how IVF clinics can support working patients and is launching the Clinic Pledge – working with Bourn Hall, the world’s first IVF clinic, to demonstrate how it can be achieved.
Bailey Fisher welcomes Ludo Chapman as Non-Exec Chair
Bailey Fisher is pleased to announce the appointment of Ludo Chapman as Non-Executive Chair. Ludo brings a wealth of experience in driving business growth and fostering innovation, as a Founder, CEO and Chair/NED. He currently runs the Innovation Practice, and sits on the board of several high-growth companies.
Broken String Biosciences appoints Steve Becker as Chief Commercial Officer
Appointment brings extensive experience to lead commercial operations and accelerate growth in key global markets
Kadans Science Partner commences work on new purpose-built wet lab facilities at Merlin Place, North Cambridge
New facilities adjacent to the Cambridge Science Park will comprise CL2 wet labs, dry labs and office space over six storeys Latest ground-up development in Cambridge delivered by Kadans Science Partner to provide the facilities needed by health, life science and teBio-Rad outlines its advances leveraging droplet digital PCR in biopharma and translational research sectors
Strategic Collaborations in Molecular Residual Disease Monitoring of Cancer and Product Launches in ddPCR Portfolio Advance Corporate Strategy in H1 2024
Anthias teaching short courses at Pittcon 2025
Anthias Consulting are delighted to be delivering four training courses at Pittcon 2025, the world’s leading annual conference and exhibition on laboratory science, as part of the event's Short Course programme.
Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer
Appointment of experienced preclinical CRO specialist to support accelerated expansion into key global marketsCambridge, UK, 23 July 2024: Metrion Biosciences Ltd, the specialist preclinical contract research organisation (CRO) and a leader
Enterprise Therapeutics doses first person with Cystic Fibrosis in Phase 2 Trial for novel therapy ETD001
Trial aims to deliver clinical proof-of-concept and assess the safety profile of novel long acting ENaC inhibitor ETD001 ETD001, a CFTR mutation agnostic approach to CF, is focussed on providing a novel treatment for members of the CF community that do not benefit fLario Therapeutics awarded $6M Grant from The Michael J. Fox Foundation for Parkinson’s Research
Award supports preclinical research of Lario’s CaV2.3 calcium channel inhibitors as a novel disease-modifying approach for treatment of Parkinson's disease Programme in collaboration with the Oxford Parkinson’s Disease CentreEdinburgh, U
BioResource participant samples used in research discovering major cause of IBD
BioResource volunteers have contributed to new research from The Francis Crick Institute - in collaboration with UCL and Imperial College London - which discovered a new biological pathway as the principal driver of Inflammatory Bowel Disease (IBD) and related conditions, and which can be targeted using existing drugs.
Ground-breaking study proves AI-driven programme has comparable effectiveness to human-delivered care while using up to 8 times fewer therapist hours
A new study by ieso Digital Health in collaboration with the and NIHR BioResource reveals that its AI-driven digital programme delivered results comparable to traditional human-led therapy for generalised anxiety. An estimated 1.2 million people in the UK are on waiting lists for NHS mental health services. Requiring up to eight times fewer therapist hours per patient, the ieso Digital Programme…
Dylan shares his inspiring story on how all families can be part of research
Dylan reveals how he had major open heart surgery at just 7 years old. He joined the D-CYPHR programme and became a DNA hero to inspire others.